These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 3986807

  • 1. Cutaneous changes during prolonged application of 12-O-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment.
    Aldaz CM, Conti CJ, Gimenez IB, Slaga TJ, Klein-Szanto AJ.
    Cancer Res; 1985 Jun; 45(6):2753-9. PubMed ID: 3986807
    [Abstract] [Full Text] [Related]

  • 2. NTP Toxicology and Carcinogenesis Studies of 1,2-Dihydro-2,2,4-Trimethylquinoline (CAS No. 147-47-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies) and the Dermal Initiation/Promotion Study in Female Sencar Mice.
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1997 Feb; 456():1-312. PubMed ID: 12587020
    [Abstract] [Full Text] [Related]

  • 3. A morphometric study of dedifferentiated and involutional dark keratinocytes in 12-O-tetradecanoylphorbol-13-acetate-treated mouse epidermis.
    Chiba M, Slaga TJ, Klein-Szanto AJ.
    Cancer Res; 1984 Jun; 44(6):2711-7. PubMed ID: 6202399
    [Abstract] [Full Text] [Related]

  • 4. Differential down-regulation of epidermal protein kinase C by 12-O-tetradecanoylphorbol-13-acetate and diacylglycerol: association with epidermal hyperplasia and tumor promotion.
    Hansen LA, Monteiro-Riviere NA, Smart RC.
    Cancer Res; 1990 Sep 15; 50(18):5740-5. PubMed ID: 2393848
    [Abstract] [Full Text] [Related]

  • 5. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
    Binder RL, Johnson GR, Gallagher PM, Stockman SL, Sundberg JP, Conti CJ.
    Cancer Res; 1998 Oct 01; 58(19):4314-23. PubMed ID: 9766659
    [Abstract] [Full Text] [Related]

  • 6. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.
    Bhasin G, Kauser H, Athar M.
    Arch Toxicol; 2004 May 01; 78(5):283-9. PubMed ID: 14997284
    [Abstract] [Full Text] [Related]

  • 7. Inversion of carcinogen-promoter sequence: effects on mouse skin tumorigenesis and cellular growth kinetics.
    Ramchandani AG, Bhisey RA, Borges AM.
    Indian J Exp Biol; 1993 Aug 01; 31(8):663-6. PubMed ID: 8270278
    [Abstract] [Full Text] [Related]

  • 8. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1995 May 01; 429():1-286. PubMed ID: 12616302
    [Abstract] [Full Text] [Related]

  • 9. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis.
    Yokota K, Gill TJ, Shinozuka H.
    Cancer Res; 1989 Aug 15; 49(16):4586-90. PubMed ID: 2501029
    [Abstract] [Full Text] [Related]

  • 10. Epidermal changes following application of 7,12-dimethylbenz(a)anthracene and 12-O-tetradecanoylphorbol-13-acetate to human skin transplanted to nude mice studied with histological species markers.
    Graem N.
    Cancer Res; 1986 Jan 15; 46(1):278-84. PubMed ID: 3079587
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.
    Huang MT, Ho CT, Wang ZY, Ferraro T, Lou YR, Stauber K, Ma W, Georgiadis C, Laskin JD, Conney AH.
    Cancer Res; 1994 Feb 01; 54(3):701-8. PubMed ID: 8306331
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM, Bolon I, Nichols A, Wohlwend A, Vassalli JD.
    Cancer Res; 2001 Feb 01; 61(3):970-6. PubMed ID: 11221892
    [Abstract] [Full Text] [Related]

  • 13. Specific alterations in keratin biosynthesis in mouse epidermis in vivo and in explant culture following a single exposure to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
    Molloy CJ, Laskin JD.
    Cancer Res; 1987 Sep 01; 47(17):4674-80. PubMed ID: 2441853
    [Abstract] [Full Text] [Related]

  • 14. Keratin gene expression in mouse skin tumors and in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate.
    Toftgard R, Yuspa SH, Roop DR.
    Cancer Res; 1985 Nov 01; 45(11 Pt 2):5845-50. PubMed ID: 2414001
    [Abstract] [Full Text] [Related]

  • 15. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.
    Xian W, Kiguchi K, Imamoto A, Rupp T, Zilberstein A, DiGiovanni J.
    Cell Growth Differ; 1995 Nov 01; 6(11):1447-55. PubMed ID: 8562483
    [Abstract] [Full Text] [Related]

  • 16. Induction of the formation of new hair follicles in mouse tail epidermis by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
    Schweizer J, Marks F.
    Cancer Res; 1977 Nov 01; 37(11):4195-201. PubMed ID: 409492
    [Abstract] [Full Text] [Related]

  • 17. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1995 May 01; 444():1-136. PubMed ID: 12595919
    [Abstract] [Full Text] [Related]

  • 18. Evidence that cutaneous carcinogen-initiated epithelial cells from mice are quiescent rather than actively cycling.
    Morris RJ, Coulter K, Tryson K, Steinberg SR.
    Cancer Res; 1997 Aug 15; 57(16):3436-43. PubMed ID: 9270010
    [Abstract] [Full Text] [Related]

  • 19. Toxicology and Carcinogenesis Studies of 4-Vinyl-1-cyclohexene Diepoxide (CAS No. 106-87-6) in F344/N Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1989 Nov 15; 362():1-249. PubMed ID: 12695779
    [Abstract] [Full Text] [Related]

  • 20. Hyperplasia of Syrian hamster epidermis induced by single but not multiple treatments with 12-O-tetradecanoylphorbol-13-acetate.
    Sisskin EE, Barrett JC.
    Cancer Res; 1981 Jan 15; 41(1):346-50. PubMed ID: 7448774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.